Pure Global AI
ANVISA registration 83234050003Active

GLYCATED HEMOGLOBIN (HbA1C)

ANVISA Registration Number: 83234050003HOPE PHARMA LTDAGOLDSITE DIAGNOSTICS INCRisk Class II
Verified
Device names
Technical name
GLYCATED HEMOGLOBIN (HbA1C)
View exact technical-name matches →
PT: HEMOGLOBINA GLICADA (HbA1C)
Commercial name
Família GPP-100 HbA1c
View exact commercial-name matches →
Risk class
Class II
Registration details
Registration Number
83234050003
Process Number
25351239512202571
CNPJ
34025812000103
Company information
Registration Holder
HOPE PHARMA LTDA
Manufacturer
GOLDSITE DIAGNOSTICS INC
Manufacturing Country
China
PT: CHINA, REPÚBLICA POPULAR
Dates and status
Publication Date
Feb 09, 2026
Validity
VIGENTE
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for GLYCATED HEMOGLOBIN (HbA1C) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 83234050003 and manufactured by GOLDSITE DIAGNOSTICS INC. The registration is held by HOPE PHARMA LTDA with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.